Co-Authors
This is a "connection" page, showing publications co-authored by Sophie Caillard and Noëlle Cognard.
Connection Strength
2.181
-
COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report. J Nephrol. 2021 08; 34(4):1045-1048.
Score: 0.946
-
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19. Am J Transplant. 2021 11; 21(11):3808-3810.
Score: 0.239
-
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses. JAMA. 2021 Jul 23.
Score: 0.239
-
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021 06; 99(6):1498-1500.
Score: 0.235
-
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021 06; 99(6):1487-1489.
Score: 0.234
-
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients. Transplantation. 2021 01 01; 105(1):158-169.
Score: 0.230
-
In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3162-3172.
Score: 0.056